CIK 0001104506
- Large accelerated filer
INSMED Inc
Sign in to watch- Ticker
- INSM
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- VA
- Entity type
- Operating
- EIN
- 541972729
- Phone
- +1 908-977-9900
- Business address
- 700 US HIGHWAY 202/206, BRIDGEWATER, NJ, 08807
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $3,100,000
- in 1 filing
Net −$3,100,000. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-02-18 | Lewis William Chair and CEO | Sale 10b5-1 | −1,253 | $79.95 | $100K | 351,683 |
| 2025-02-18 | Lewis William Chair and CEO | Sale 10b5-1 | −16,743 | $81.08 | $1.4M | 334,940 |
| 2025-02-18 | Lewis William Chair and CEO | Sale 10b5-1 | −754 | $81.67 | $62K | 334,186 |
| 2025-02-18 | Lewis William Chair and CEO | Exercise or conversion 10b5-1 | +6,830 | $10.85 | $74K | 240,754 |
| 2025-02-18 | Lewis William Chair and CEO | Sale 10b5-1 | −456 | $80.00 | $36K | 240,298 |
| 2025-02-18 | Lewis William Chair and CEO | Sale 10b5-1 | −6,074 | $81.07 | $492K | 234,224 |
| 2025-02-18 | Lewis William Chair and CEO | Sale 10b5-1 | −300 | $81.81 | $25K | 233,924 |
| 2025-02-18 | Lewis William Chair and CEO | Exercise or conversion · Stock Option (right to buy) 10b5-1 | −18,750 | 37,500 | ||
| 2025-02-18 | Lewis William Chair and CEO | Exercise or conversion · Stock Option (right to buy) 10b5-1 | −6,830 | 204,970 | ||
| 2025-02-18 | Bonstein Sara Chief Financial Officer | Sale 10b5-1 | −17,622 | $80.28 | $1.4M | 119,563 |
| 2025-02-18 | Bonstein Sara Chief Financial Officer | Sale 10b5-1 | −700 | $81.00 | $57K | 118,863 |
| 2025-02-12 | Bonstein Sara Chief Financial Officer | Sale 10b5-1 | −5,019 | $80.00 | $402K | 137,185 |
| 2025-02-11 | Bonstein Sara Chief Financial Officer | Sale 10b5-1 | −13,302 | $80.00 | $1.1M | 142,204 |
| 2025-02-10 | Adsett Roger Chief Operating Officer | Sale 10b5-1 | −11,053 | $77.02 | $851K | 178,004 |
| 2025-02-10 | Adsett Roger Chief Operating Officer | Sale 10b5-1 | −5,781 | $78.36 | $453K | 172,223 |
| 2025-02-10 | Adsett Roger Chief Operating Officer | Sale 10b5-1 | −26,141 | $79.33 | $2.1M | 146,082 |
| 2025-02-10 | Flammer Martina M.D. Chief Medical Officer | Sale 10b5-1 | −9,729 | $77.02 | $749K | 128,264 |
| 2025-02-10 | Flammer Martina M.D. Chief Medical Officer | Sale 10b5-1 | −5,089 | $78.36 | $399K | 123,175 |
| 2025-02-10 | Flammer Martina M.D. Chief Medical Officer | Sale 10b5-1 | −23,010 | $79.33 | $1.8M | 100,165 |
| 2025-02-07 | Flammer Martina M.D. Chief Medical Officer | Sale | −60 | $79.59 | $5K | 137,993 |
Page 29 of 42 · 826 trades